SCHEMBL6789647

SCHEMBL6789647

CC(C1CCC(=O)CC1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.42
DPP4 P27487 1/20 0.42
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 5/20 0.41
HTT P42858 1/20 0.41
NPC1 O15118 1/20 0.40
DRD2 P14416 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
KMT2A Q03164 3/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.38
MAPT P10636 1/20 0.38
CASP3 P42574 1/20 0.38
ALOX15 P16050 1/20 0.38
CHRM2 P08172 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6925072 0.85 ALDH1A1 (0.49) TDP1DPP4NR1H2NR1H3LMNA
SCHEMBL6925075 0.85 ALDH1A1 (0.49) TDP1DPP4NR1H2NR1H3LMNA
SCHEMBL6881201 0.78 HTR3E (0.42) TDP1LMNAALDH1A1HTTNPC1
Hydrochloric Acid SCHEMBL27657147 0.73 HTR2B (0.40) TDP1LMNAALDH1A1HTTHTR2A
SCHEMBL16169047 0.72 TDP1 (0.45) TDP1LMNAALDH1A1HTTNPC1
SCHEMBL17983185 0.72 ALDH1A1 (0.46) TDP1DPP4NR1H2NR1H3LMNA
SCHEMBL14928512 0.72 TDP1 (0.45) TDP1LMNAALDH1A1HTTNPC1
SCHEMBL16169045 0.70 TDP1 (0.42) TDP1LMNAALDH1A1HTTNPC1
SCHEMBL14928513 0.70 ALDH1A1 (0.44) TDP1LMNAALDH1A1HTTNPC1
SCHEMBL15081302 0.70 TDP1 (0.42) TDP1LMNAALDH1A1HTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825230-B2 PEROXY COMPOUNDS SUCH AS ADAMANTANE-2-SPIRO-3'-8'-((1'S)-10'-CAMPHORSULFONYL)-1',2',4'-TRIOXA-8' -AZASPIRO(4.5) DECANE, USED FOR PROPHYLAXIS OF MALARIA OR SCHISTOSOMIASIS INFECTIONS MEDICINES FOR MALARIA VENTURE MMV (CH) 2004-11-30 US disclosed
EP-1414813-A1 1,2,4-TRIOXOLANE ANTIMALARIALS Medicines for Malaria Venture (CH) 2004-05-06 EP disclosed
US-20040039008-A1 Spiro and dispiro 1,2,4-trioxolane antimalarials MEDICINES FOR MALARIA VENTURES MMV (CH) 2004-02-26 US disclosed
WO-2003000676-A1 1,2,4-TRIOXOLANE ANTIMALARIALS MEDICINES FOR MALARIA VENTURE (CH) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039008-A1 Spiro and dispiro 1,2,4-trioxolane antimalarials DHODH, THPO, SQLE TDP1 2912/4885DPP4 856/4885NR1H2 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.